Critical appraisal of translational research models for suitability in performance assessment of cancer centers

Oncologist

Volumn 17, Issue 12, 2012, Pages

  Rajan, Abinaya ^a,b   Sullivan, Richard ^c   Bakker, Suzanne ^a   van Harten, Wim H ^a,b  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b UNIVERSITY OF TWENTE   (Netherlands)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cancer centers; Models; Performance assessment; Performance improvement; Translational medical research

Indexed keywords

ALGORITHM; ARTICLE; BIOLOGICAL MODEL; CANCER CENTER; ONCOLOGY; PRIORITY JOURNAL; PROCESS MODEL; SYSTEM ANALYSIS; SYSTEMATIC REVIEW; T MODEL; TRANSLATIONAL RESEARCH; TYPE 1 TRANSLATION; TYPE 2 TRANSLATION; TYPE 3 TRANSLATION; TYPE 4 TRANSLATION;

EVIDENCE-BASED MEDICINE; HEALTH FACILITIES; HUMANS; MODELS, THEORETICAL; NEOPLASMS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84871557704     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2012-0216     Document Type: Article

References (34)

1. Eckhouse S, Lewison G, Sullivan R. Trends in the global funding and activity of cancer research. Mol Oncol 2008;2:20-32.
2. Westfall JM, Mold J, Fagnan L. Practice-based research: "Blue highways" on the NIH roadmap. JAMA 2007;297:403-406.
3. Balas EA, Boren SA. Managing Clinical Knowledge for Health Care Improvement. Yearbook of Medical Informatics. Stuttgart, Germany: Schattauer Verlagsgesellschaft mbH, 2000.
4. Contopoulos-Ioannidis D, Alexiou G, Gouvias T et al. Life cycle of translational research for medical interventions. Science 2008;321:1298-1299.
5. Pray L. Gleevec: The breakthrough in cancer treatment. Nat Educ 2008;1:1.
6. Organisation for Economic Co-operation and Development. Effects of European Union Accession, Part 1: Budgeting and Financial Control. Paris, France: Organisation for Economic Co-operation and Development, 1998.
7. Trochim W, Kane C, Graham M et al. Evaluating translation research: A process marker model. Clin Transl Sci 2011;4:153-162.
8. Morris ZS, Wooding S, Grant J. The answer is 17 years, what is the question: Understanding time lags in translational research. J R Soc Med 2011;104:510-520.
9. Rubio DM, Schoenbaum EE, Lee LS et al. Defining translational research: Implications for training. Acad Med 2010;85:470-475.
10. Zehrouni E. The NIH roadmap. Science 2003;302: 63-72.
11. Institute of Medicine. Crossing the quality chasm: A new health system for the 21st century. Washington DC: Institute of Medicine, 2001.
12. Sung NS, Crowley WFJ, Genel M et al. Central challenges facing the national clinical research enterprise. JAMA 2003;289:1278-1287.
13. Dougherty D, Conway PH. The "3T's" road map to transform US health care. JAMA 2008;299:2319-2321.
14. Thornicroft G, Lempp H, Tansella M. The place of implementation science in the translational medicine continuum. Psychol Med 2011;41:2015-2021.
15. National Institute for Health Research. Better Research for Better Health. London, UK: Department of Health, 2006.
16. Craig P, Dieppe P, Macintyre S et al. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 2008;337:a1655.
17. Crowley WF Jr., Sherwood L, Salber P et al. Clinical research in the United States at a crossroads: proposal for a novel public-private partnership to establish a national clinical research enterprise. JAMA 2004;291: 1120-1126.
18. The President's Cancer Panel. Translating Research into Cancer Care: Delivering on the Promise. Washington DC: Department of Health and Human Services, 2005.
19. Khoury MJ, Gwinn M, Yoon PW et al. The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention. Genet Med 2007;9:665-674.
20. Khoury MJ, Little J, Burke W, eds. Human Genome Epidemiology: Scope and Strategies. New York: Oxford University Press, 2004.
21. Haddow JE, Palomaki GE. A model process for the evaluating data on emerging genetic tests. In: Khoury MJ, Little J, Burke W, editors. Human Genome Epidemiology: Scope and Strategies. New York: Oxford University Press, 2004:217-233.
22. Drolet BC, Lorenzi NM. Translational research: Understanding the continuum from bench to bedside. Transl Res 2011;157:1-5.
23. Ernest TH, Matrisian LM, Nelson WG et al. The Translational Research Working Group developmental pathways: Introduction and overview. Clin Cancer Res 2008;14:5664-5671.
24. Schweikhart SA, Dembe AE. The applicability of Lean and Six Sigma techniques to clinical and translational research. J Investig Med 2009;57:748-755.
25. Lane JP, Flagg JL. Translating three states of knowledge: Discovery, invention, and innovation. Implement Sci 2010;5:1-14.
26. Ogilvie D, Craig P, Griffin S et al. A translational framework for public health research. BMC Public Health 2009;9:116.
27. Graham ID, Logan J, Harrison MB et al. Lost in knowledge translation: Time for a map? J Contin Educ Health Prof 2006;26:13-24.
28. Cooksey D. A review of UK health research funding. London: HM Treasury; 2006.
29. Jones DS, Cambrioso A, Mogoutov A. Detection and characterization of translational research in cancer and cardiovascular medicine. J Transl Med 2011;9:57.
30. Schwab ED, Pienta KJ. Cancer as a complex adaptive system. Med Hypotheses 1996;47:235-241.
31. Amidon DM. The challenge of fifth generation R&D. Res Tech Manage 1996;39:33-41.
32. Johnson G, Scholes K, Whittington R. Exploring Corporate Strategy, 8th Ed. Essex, UK: Prentice Hall, 2008.
33. Chubb I. Can Australia afford to fund translational research? Presented at: Australian Government Biobreakfast; April 3, 2012; Melbourne, Australia.
34. Pozen R, Heather K. Defining success for translational research organisations. Sci Transl Med 2011; 3:94cm20.